Search results
Results from the WOW.Com Content Network
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $3.12, marking a -0.32% move from the previous day.
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $2.84, moving -0.35% from the previous trading session.
Following the resignation of all its independent directors Tuesday, the stock fell to its rock bottom: $0.30. (As of midday Wednesday, it’s back to $0.36.) ... DNA test sales have dropped off.
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
He became a member of Silicon Investor in August 1998, and created his own message board, "Anthony@Equity Investigations, Dear Anthony”. [15] In 1999, Silicon Investor banned Anthony Elgindy because his controversial postings violated the Terms and Conditions of Silicon Investor but later reinstated his membership after a user-vote.
Its stock is a tracking stock of Applera, along with the tracking stock of Applera's larger Applied Biosystems Group business unit. Celera sequenced the human genome at a fraction of the cost of the publicly funded Human Genome Project (HGP), using about $300 million of private funding versus approximately $3 billion of taxpayer dollars.
Boards exist to check a CEO’s power and to protect companies when the business is in trouble. In the case of 23andMe, former employees say, the signs were there. View this interactive chart on ...
Gregory Stock is an American biophysicist, best-selling author, biotechnology entrepreneur, and the former director of the Program on Medicine, Technology and Society at UCLA School of Medicine. His interests lie in the scientific and evolutionary as well as ethical, social and political implications of today's revolutions in the life sciences ...